Measles-containing-vaccine first-dose (MCV1) immunization coverage in Lebanon
Lebanon: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 67.0% in 2025. ▲ Rising
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Lebanon, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine first-dose (mcv1) immunization coverage in Lebanon stood at 67.0%.
That represents a change of down 18.3% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Lebanon peaked at 89.0% in 2008 and was at its lowest, 53.0%, in 2003.
That places Lebanon 169th out of 194 countries with data for 2025, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Lebanon, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 71.0% | — |
| 2001 | 65.0% | -8.5% |
| 2002 | 59.0% | -9.2% |
| 2003 | 53.0% | -10.2% |
| 2004 | 60.0% | +13.2% |
| 2005 | 67.0% | +11.7% |
| 2006 | 75.0% | +11.9% |
| 2007 | 82.0% | +9.3% |
| 2008 | 89.0% | +8.5% |
| 2009 | 88.0% | -1.1% |
| 2010 | 86.0% | -2.3% |
| 2011 | 85.0% | -1.2% |
| 2012 | 83.0% | -2.4% |
| 2013 | 82.0% | -1.2% |
| 2014 | 82.0% | +0.0% |
| 2015 | 82.0% | +0.0% |
| 2016 | 82.0% | +0.0% |
| 2017 | 82.0% | +0.0% |
| 2018 | 82.0% | +0.0% |
| 2019 | 82.0% | +0.0% |
| 2020 | 74.0% | -9.8% |
| 2021 | 67.0% | -9.5% |
| 2022 | 67.0% | +0.0% |
| 2023 | 67.0% | +0.0% |
| 2024 | 67.0% | +0.0% |
| 2025 | 67.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 70.9% | 53.0% | 89.0% | 10 |
| 2010s | 82.8% | 82.0% | 86.0% | 10 |
| 2020s | 68.2% | 67.0% | 74.0% | 6 |
Countries ranked near Lebanon
More health data for Lebanon
- Un projection of annual infant deaths, annual growth rate -2.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.46 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,106 deaths per 1,000 people (2090)
- Number of infants who die before age 1 185 deaths (2100)
- Population ages 0-14, female, annual growth rate -1.55 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 0-14, female, per capita 0.1246 units per person (2025)
- Population ages 0-14, male, annual growth rate -1.56 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 0-14, male, per capita 0.1312 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Lebanon?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Lebanon was 67.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Lebanon?
- The highest recorded value was 89.0% in 2008.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Lebanon?
- The lowest recorded value was 53.0% in 2003.
- How does Lebanon rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Lebanon ranks 169th out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Lebanon?
- Over the last ten years it is down 18.3%. The long-run trend across the full record is rising.
- Where does this Lebanon data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).